Transendothelial lipoprotein transport and regulation of endothelial permeability and integrity by lipoproteins

Current Opinion in Lipidology

Volumn 20, Issue 3, 2009, Pages 197-205

  Von Eckardstein, Arnold ^a   Rohrer, Lucia ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; RAC PROTEIN; SCAVENGER RECEPTOR BI; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR;

CELL DIFFERENTIATION; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; REVIEW;

ANIMALS; CELL SURVIVAL; ENDOTHELIAL CELLS; ENDOTHELIUM; HUMANS; LIPOPROTEINS; PERMEABILITY; PROTEIN TRANSPORT;

EID: 67049155944     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOL.0b013e32832afd63     Document Type: Review

References (73)

1. Hasham SN, Pillarisetti S. Vascular lipases, inflammation and atherosclerosis. Clin Chim Acta 2006; 372:179-183.
2. Wong H, Schotz MC. The lipase gene family. J Lipid Res 2002; 43:993-999.
3. Beigneux AP, Davies BS, Bensadoun A, et al. GPIHBP1: a GPI-anchored protein required for the lipolytic processing of triglyceride-rich lipoproteins. J Lipid Res 2008 [Epub ahead of print. A very informative review on the role of the lipoprotein lipase receptor GPIHBP1.
4. Weinstein MM, Yin L, Beigneux AP, et al. Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1 -deficient mice. J Biol Chem 2008; 283:34511-34518.
5. Beigneux AP, Davies BS, Gin P, et al. Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab 2007; 5:279-291.
6. Kanda T, Brown JD, Orasanu G, et al. PPARgamma in the endothelium regulates metabolic responses to high-fat diet in mice. J Clin Invest 2009; 119:110-124. The conditional knockout of PPARγ in endothelial cells revealed a specific important contribution of the endothelium to the regulation of fatty acid and triglyceride metabolism. Fed with a high-fat diet, the mice presented with reduced obesity and vasoreactivity as well as with increased insulin sensitivity, hypertrigly-ceridaemia and hyperacylaemia due to lipoprotein lipase inhibition.
7. Zheng XY, Liu L. Remnant-like lipoprotein particles impair endothelial function: direct and indirect effects on nitric oxide synthase. J Lipid Res 2007; 48:1673-1680.
8. Wheeler-Jones CP. Chylomicron remnants: mediators of endothelial dysfunction? Biochem Soo Trans 2007; 35 (Pt 3):442-445.
9. Dunn S, Vohra RS, Murphy JE, et al. The lectin-like oxidized low-density- lipoprotein receptor: a pro-inflammatory factor in vascular disease. Biochem J 2008; 409:349-355. A very concise review on LOX-1 and its role in vascular biology and atherosclerosis.
10. Argraves KM, Argraves WS. HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects. J Lipid Res 2007; 48: 2325-2333.
11. Yatomi Y. Plasma sphingosine 1-phosphate metabolism and analysis. Bio- chim Biophys Acta 2008; 1780:606-611. A very concise review on the biochemistry of S1P.
12. Mineo C, Deguchi H, Griffin JH, Shaul PW. Endothelial and antithrombotic actions of HDL. Circ Res 2006; 98:1352-1364.
13. van der Vusse GJ, van Bilsen M, Glatz JF, et al. Critical steps in cellular fatty acid uptake and utilization. Mol Cell Biochem 2002; 239:9-15.
14. Gosselet F, Candela P, Sevin E, et al. Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood-brain barrier: use of an in vitro model. Brain Res 2009; 1249:34-42.
15. Fuchs R, Ellinger I. Endocytic and transcytotic processes in villous syncytio-trophoblast: role in nutrient transport to the human fetus. Traffic 2004; 5:725-738.
16. Plosch T, van Straten EM, Kuipers F. Cholesterol transport by the placenta: placental liver X receptor activity as a modulator of fetal cholesterol metabolism? Placenta 2007; 28:604-610.
17. Hanebutt FL, Demmelmair H, Schiessl B, et al. Long-chain polyunsaturated fatty acid (LC-PUFA) transfer across the placenta. Clin Nutr 2008; 27:685-693.
18. Björkhem I. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J Intern Med 2006; 260:493-508.
19. Ohtsuki S, Ito S, Matsuda A, et al. Brain-to-blood elimination of 24S-hydro-xycholesterol from rat brain is mediated by organic anion transporting polypeptide 2 (oatp2) at the blood-brain barrier. J Neurochem 2007; 103: 1430-1438.
20. Tabas I, Williams KJ, Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007; 116:1832-1844.
21. Simionescu M. Implications of early structural-functional changes in the endothelium for vascular disease. Arterioscler Thromb Vase Biol 2007; 27:266-274.
22. Rippe B, Rosengren Bl, Carlsson O, Venturoli D. Transendothelial transport: the vesicle controversy. J Vase Res 2002; 39:375-390.
23. Frank PG, Pavlides S, Lisanti MP. Caveolae and transcytosis in endothelial cells: role in atherosclerosis. Cell Tissue Res 2009; 335:41-47. A very informative review on the role of caveolae in transendothelial albumin and LDL transport and its importance in atherosclerosis.
24. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev 2006; 86:279-367.
25. Mineo C, Shaul PW. Role of high-density lipoprotein and scavenger receptor B type I in the promotion of endothelial repair. Trends Cardiovasc Med 2007; 17:156-161.
26. Argraves KM, Gazzolo PJ, Groh EM, et al. High density lipoprotein-associated sphingosine 1 -phosphate promotes endothelial barrier function. J Biol Chem 2008; 283:25074-25081. This is the first report showing that HDL regulates the permeability of endothelial cells cultivated in a transwell system. Not unexpected, S1P was identified as the agonist exerting this effect.
27. Zhu W, Saddar S, Seetharam D, et al. The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity. Circ Res 2008; 102:480-487. By both in-vitro and in-vivo experiments, the authors show that the SR-BI adaptor protein PDZK1 is crucially required for mediating several signalling events of HDL and SR-BI such as stimulation of eNOS and cell migration. PDZK1-/- mice show a defect in reendothelialization of injured carotid arteries which cannot be restored by PDZK1 gene transfer into the liver.
28. Jones AR, Shusta EV. Blood-brain barrier transport of therapeutics via receptor-mediation. Pharm Res 2007; 24:1759-1771.
29. Spencer BJ, Verma IM. Targeted delivery of proteins across the blood-brain barrier. Proc Natl Acad Sci U S A 2007; 104:7594-7599.
30. Kratzer I, Wernig K, Panzenboeck U, et al. Apolipoprotein A-l coating of protamine-oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood-brain barrier. J Control Release 2007; 117:301-311.
31. von Eckardstein A. HDL: a difficult friend. Drug Discov Today Dis Mech 2008; 5:e305-e324.
32. Schwenke DC, Carew TE. Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries. Arteriosclerosis 1989; 9:908-918.
33. Nordestgaard BG, Wootton R, Lewis B. Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media. Arterioscler Thromb Vase Biol 1995; 15:534-542.
34. Kornerup K, Nordestgaard BG, Jensen TK, eta/. Transendothelial exchange of low-density lipoprotein is unaffected by the presence of severe atherosclerosis. Cardiovasc Res 2004; 64:337-345.
35. Jensen JS, Feldt-Rasmussen B, Jensen KS, et al. Transendothelial lipoprotein exchange and microalbuminuria. Cardiovasc Res 2004; 63:149-154.
36. Kornerup K, Nordestgaard BG, Feldt-Rasmussen B, et al. Increased trans-vascular low density lipoprotein transport in insulin dependent diabetes: a mechanistic model for development of atherosclerosis. Atherosclerosis 2003; 170:163-168.
37. Born GV, Medina R, Shafi S, Cardona-Sanclemente LE. Factors influencing the uptake of atherogenic plasma proteins by artery walls. Biorheology 2003; 40:13-22.
38. van den Berg BM, Spaan JA, Vink H. Impaired glycocalyx barrier properties contribute to enhanced intimal low-density lipoprotein accumulation at the carotid artery bifurcation in mice. Pflugers Arch 2009; 457:1199-1206.
39. Komarova YA, Mehta D, Malik AB. Dual regulation of endothelial junctional permeability. Sci STKE 2007; 2007:re8.
40. Hu G, Minshall RD. Regulation of transendothelial permeability by Src kinase. Microvaso Res 2009; 77:21-25.
41. Frank PG, Pavlides S, Cheung MW, et al. Role of caveolin-1 in the regulation of lipoprotein metabolism. Am J Physiol Cell Physiol 2008; 295:C242-C248. This is a systematic analysis of lipoprotein metabolism in mice with a knockout of caveolin-1. The mice show hypertriglyceridaemia despite reduced VLDL production as well as high HDL cholesterol levels. Most interestingly arteries of cavl"/" mice show a decreased uptake of LDL into arteries supporting the concept that caveolin-1 is crucial for transendothelial transcytosis of LDL.
42. Frank PG, Lee H, Park DS, et al. Genetic ablation of caveolin-1 confers protection against atherosclerosis. Arterioscler Thromb Vase Biol 2004; 24:98-105.
43. Goti D, Balazs Z, Panzenboeck U, et al. Effects of lipoprotein lipase on uptake and transcytosis of low density lipoprotein (LDL) and LDL-associated alpha-tocopherol in a porcine in vitro blood-brain barrier model. J Biol Chem 2002; 277:28537-28544.
44. Dehouck B, Fenart L, Dehouck MP, et al. A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier. J Cell Biol 1997; 138:877-889.
45. Pan W, Kastin AJ, Zankel TC, et al. Efficient transfer of receptor-associated protein (RAP) across the blood-brain barrier. J Cell Sci 2004; 117 (Ft 21): 5071-5078.
46. Chao WT, Fan SS, Chen JK, Yang VC. Visualizing caveolin-1 and HDL in cholesterol-loaded aortic endothelial cells. J Lipid Res 2003; 44:1094-1099.
47. Rohrer L, Cavelier C, Fuchs S, et al. Binding, internalization and transport of apolipoprotein A-l by vascular endothelial cells. Biochim Biophys Acta 2006; 1761:186-194.
48. Cavelier C, Rohrer L, von Eckardstein A. ATP-Binding cassette transporter A1 modulates apolipoprotein A-l transcytosis through aortic endothelial cells. Circ Res 2006; 99:1060-1066.
49. Rohrer L, Ohnnsorg PM, Lehner M. et al. HDL transport through aortic endothelial cells involves scavenger receptor Bl and ATP binding cassette transporter G1. Circ Res 2009. [Epub ahead of print] Radiolabeled HDLs are shown to be transported from apical to basolateral through aortic endothelial cells by transcytosis. This transport is associated with particle size changes and is partially inhibited by knockdown of either ABCG1 or SR-BI.
50. Balazs Z, Panzenboeck U, Hammer A, et al. Uptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood-brain barrier model. J Neurochem 2004; 89:939-950.
51. Zampetaki A, Kirton JP, Xu Q. Vascular repair by endothelial progenitor cells. Cardiovasc Res 2008; 78:413-421. A very informative review on the biology and clinical importance of EPCs.
52. Li D, Mehta JL. Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vase Biol 2000; 20:1116-1122.
53. Shin HK, Kim YK, Kim KY, et al. Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein re-ceptor-1 activation: prevention by cilostazol. Circulation 2004; 109:1022-1028.
54. Norata GD, Pirillo A, Callegari E, et al. Gene expression and intracellular pathways involved in endothelial dysfunction induced by VLDL and oxidised VLDL. Cardiovasc Res 2003; 59:169-180.
55. Sue I, Escargueil-Blanc I, Troly M, et al. HDL and apoA prevent cell death of endothelial cells induced by oxidized LDL. Arterioscler Thromb Vase Biol 1997; 17:2158-2166.
56. Speidel MT, Booyse FM, Abrams A, et al. Lipolyzed hypertriglyceridemia serum and triglyceride-rioh lipoprotein cause lipid accumulation in and are cytotoxic to cultured human endothelial cells. High density lipoproteins inhibit this cytotoxicity. Thromb Res 1990; 58:251-264.
57. Sugano M, Tsuchida K, Makino N. High-density lipoproteins protect endothelial cells from tumor necrosis factor-alpha-induced apoptosis. Biochem Biophys Res Commun 2000; 272:872-876.
58. Kimura T, Sato K, Malchinkhuu E, et al. High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1 -phosphate and its receptors. Arterioscler Thromb Vase Biol 2003; 23:1283-1288.
59. Nofer JR, Levkau B, Wolinska I, et al. Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphin-golipids. J Biol Chem 2001; 276:34480-34485.
60. Kimura T, Sato K, Kuwabara A, er a/. Sphingosine 1 -phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells. J Biol Chem 2001; 276:31780-31785.
61. Rosenfeld SI, Packman CH, Leddy JP. Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins. J Clin Invest 1983; 71:795-808.
62. Nofer JR, Fobker M, Höbbel G, et al. Activation of phosphatidylinositol-specific phospholipase C by HDL-associated lysosphingolipid. Involvement in mitogenesis but not in cholesterol efflux. Biochemistry 2000; 39:15199-15207.
63. von Otte S, Paletta JR, Becker S, et al. Follicular fluid high density lipoprotein-associated sphingosine 1 -phosphate is a novel mediator of ovarian angiogen-esis. J Biol Chem 2006; 281:5398-5405.
64. Miura S, Fujino M, Matsuo Y, et al. High density lipoprotein-induced angio-genesis requires the activation of Ras/MAP kinase in human coronary artery endothelial cells. Arterioscler Thromb Vase Biol 2003; 23:802-808.
65. Miura S, Tanigawa H, Matsuo Y, et al. Ras/Raf1 -dependent signal in sphin-gosine-1-phosphate-induced tube formation in human coronary artery endothelial cells. Biochem Biophys Res Commun 2003; 306:924-929.
66. Seetharam D, Mineo C, Gormley AK, et al. High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ Res 2006; 98:63-72.
67. Tso C, Martinic G, Fan WH, et al. High-density lipoproteins enhance progenitor-mediated endothelium repair in mice. Arterioscler Thromb Vase Biol 2006; 26:1144-1149.
68. Sumi M, Sata M, Miura S, et al. Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis. Arterioscler Thromb Vase Biol 2007; 27:813-818.
69. Feng Y, Jacobs F, Van Craeyveld E, et al. Human ApoA-l transfer attenuates transplant arteriosclerosis via enhanced incorporation of bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vase Biol 2008; 28:278-283. The researchers demonstrate that gene transfer of human apoA-l into wild type mice increases the number of circulating EPCs, enhances their incorporation into allografts, promotes endothelial regeneration and attenuates neointima formation in a murine model of transplant arteriosclerosis.
70. *] in irradiated mice, which received bone marrow from either SR-BI+/+ or SR-BI-/- mice. The beneficial effects of apoA-l gene transfer on EPC number and function as well as allograft vas culopathy depended on the expression of SR-BI. The authors also show that HDL/SR-BI interaction activates ERK and increases nitric oxide production in EPCs.
71. Noor R, Shuaib U, Wang CX, et al. High-density lipoprotein cholesterol regulates endothelial progenitor cells by increasing eNOS and preventing apoptosis. Atherosclerosis 2007; 192:92-99.
72. Petoumenos V, Nickenig G, Werner N. High density lipoprotein exerts vasculoprotection via endothelial progenitor cells. J Cell Mol Med 2008. [Epub ahead of print]
73. van Oostrom O, Nieuwdorp M, Westerweel PE, et al. Reconstituted HDL increases circulating endothelial progenitor cells in patients with type 2 diabetes. Arterioscler Thromb Vase Biol 2007; 27:1864-1865.